This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Critical Care/ Intensive Care Medicine  • Pediatric/ Neonatal Critical Care  • Pediatrics  • Neonatology and Infant Care  • Pediatrics, Other  • Immunization  • Pulmonary Diseases  • Pneumonia  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2009;301(12):1220-1222.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2009;58:1-4

1 figure, 1 table omitted

Streptococcus pneumoniae is the leading bacterial cause of community-acquired pneumonia hospitalizations and an important cause of bacteremia and meningitis, especially among young children and older adults.^1-2 A 7-valent pneumococcal conjugate vaccine (PCV7) was licensed and the Advisory Committee on Immunization Practices formulated recommendations for its use in infants and children in February 2000.² Vaccination coverage rapidly increased during the second half of 2000, in part through funding by CDC's Vaccines for Children program. Subsequently, active population- and laboratory-based surveillance demonstrated substantial reductions in invasive pneumococcal disease (IPD) among children and adults.³ In addition, decreases in hospitalizations and ambulatory-care visits for all-cause pneumonia also were reported.^4-5 To gauge whether the effects of PCV7 on reducing pneumonia continue, CDC is monitoring pneumonia hospitalizations by using data from the Nationwide Inpatient Sample. This report provides an update for 2005 and 2006, the most recent years for . . . [Full Text of this Article]

Reported by:



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?